Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 1 Hematologic Neoplasms 1

Interventions

Cyclophosphamide 61 Rituximab 50 fludarabine 34 Prednisone 33 Doxorubicin 28 Biopsy 26 Vincristine 25 Specimen Handling 22 Magnetic Resonance Spectroscopy 20 Bendamustine Hydrochloride 19 pembrolizumab 16 Lenalidomide 16 obinutuzumab 14 fludarabine phosphate 14 Etoposide 14 venetoclax 13 Tacrolimus 11 Mycophenolic Acid 10 Melphalan 10 Dexamethasone 10 zanubrutinib 9 ibrutinib 9 acalabrutinib 9 Radiotherapy 9 Gemcitabine 9 Cytarabine 9 Busulfan 9 Whole-Body Irradiation 8 Mesna 8 Filgrastim 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma × maribavir × 1 year × Clear all

NCT07014319 2025-12-04

MALMBA

Seoul National University Hospital

Phase 2 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡